Use of CD3 antibodies in transplantation and autoimmune diseases.
Chatenoud
L
L
Hôpital Necker, Paris, France.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000628:therapy*; D017252:CD3 Complex / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis; D006801:Humans; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D013577:Syndrome; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous / Q000276:immunology*
D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D016207:Cytokines; D016853:Muromonab-CD3